FDA guidance on Bayesian clinical trials
Statistical Modeling, Causal Inference, and Social Science 2026-01-15
Summary:
This is Witold. The Food & Drug Administration just released a guidance for industry document on “Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products”: This draft guidance provides guidance to sponsors and applicants submitting investigational new … Continue reading →